EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 39 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,383,000 | +605.8% | 436,995 | +597.0% | 0.06% | +916.7% |
| Q2 2022 | $621,000 | +356.6% | 62,699 | +353.6% | 0.01% | +500.0% |
| Q1 2022 | $136,000 | -33.7% | 13,824 | -34.2% | 0.00% | -50.0% |
| Q4 2021 | $205,000 | -0.5% | 21,024 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $206,000 | +77.6% | 21,024 | +78.2% | 0.00% | +100.0% |
| Q2 2021 | $116,000 | – | 11,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SkyView Investment Advisors, LLC | 71,773 | $717 | 0.22% |
| EcoR1 Capital, LLC | 200,000 | $1,998,000 | 0.06% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,483 | $34,795 | 0.00% |
| Tower Research Capital LLC (TRC) | 657 | $7 | 0.00% |
| DEUTSCHE BANK AG\ | 21,923 | $219,011 | 0.00% |